Catalyst Wire Dossier Catalyst Wire Dossier

Anlotinib hydrochloride capsules

anlotinib hydrochloride · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Anlotinib hydrochloride capsules, covering 2019-08-29 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma [Phase 2]

See pricing